Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-AV-1451 PET Imaging in Professional Fighters
NCT02278354Phase 1Completed
- Sponsor
- Avid Radiopharmaceuticals
- Start
- Feb 2015
- Primary completion
- Feb 2017
- Countries
- 1
01
Overview
Phase 1, open-label trial (2 arms), sponsored by Avid Radiopharmaceuticals. Primary endpoints: Flortaucipir Imaging (Quantitative) Between Cognitive Groups, Flortaucipir Imaging (Quantitative) Between Fighter Groups and 2 more. Started Feb 2015; status: completed.
Beyond the preview
Go deeper on NCT02278354.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02278354.